VAERS Explorer
Back to explore

Report #2880267

Received Dec 31, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
74 yrs
State
GA
Recovered
Not recovered
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2UNKIM / LA

Symptoms (5)

ArthralgiaInappropriate schedule of product administrationInjection site painPeriarthritisSleep disorder

Symptom narrative

she had injection site pain in her left upper arm; the second dose she developed a frozen left shoulder; the shoulder pain comes and goes; The patient received her second Shingrix dose about 1 and 1/2 years ago; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 74-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (received first dose about 2 and a half years ago). On an unknown date, the patient received the 2nd dose of Shingrix (intramuscular, left deltoid). On an unknown date, immediately after receiving Shingrix, the patient experienced injection site pain (Verbatim: she had injection site pain in her left upper arm), frozen shoulder (Verbatim: the second dose she developed a frozen left shoulder), shoulder pain (Verbatim: the shoulder pain comes and goes) and drug dose administration interval too long (Verbatim: The patient received her second Shingrix dose about 1 and 1/2 years ago). The patient was treated with cortisone acetate (Cortisone). The outcome of the injection site pain was not resolved and the outcome of the frozen shoulder was resolving and the outcome of the shoulder pain was not reported and the outcome of the drug dose administration interval too long was not applicable. It was unknown if the reporter considered the injection site pain, frozen shoulder and shoulder pain to be related to Shingrix. It was unknown if the company considered the injection site pain, frozen shoulder and shoulder pain to be related to Shingrix. Additional Information: GSK Receipt Date: 30-DEC-2025 The patient reported that she had received her second Shingrix dose in 2024, about one and a half years ago, and immediately after the second dose, she experienced injection site pain in her left upper arm. The pain persisted for one and a half years. Due to the pain, she was unable to sleep on her left side. The patient stated that right after the second dose, she developed a frozen left shoulder. She consulted an orthopedist and received a cortisone shot along with several weeks of physical therapy for her shoulder. The frozen shoulder improved, but the shoulder pain continued to come and go, and nothing else was reported. The batch number was not provided and a request for this information has been made.